Long-Term Use of Rilutek Can Improve ALS Patients’ Survival, Italian Study Finds
ALS patients who took Rilutek (riluzole) for at least three-fourths of the time they had their disease survived longer than those who took it less, an Italian study reports. Rilutek is the first ALS treatment to obtain U.S. Food and Drug Administration approval. Scientists are still not sure how it…